Kennedy Capital Management, Inc. Agenus Inc Transaction History

Kennedy Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $1,060 - $1,919	1,684 Added 1.76%	97,278 $80,000
Q3 2023 Nov 14, 2023	BUY	$1.12 - $1.88 $2,514 - $4,220	2,245 Added 2.4%	95,594 $108,000
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $103,898 - $161,796	79,312 Added 565.02%	93,349 $149,000
Q1 2023 May 15, 2023	BUY	$1.45 - $2.95 $20,353 - $41,409	14,037 New	14,037 $21,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.